Study on the anti-glycation active constituents of Withania somnifera based on molecular docking and experimental verification
Withania somnifera (L.) Dunal, commonly known as Ashwagandha, has been demonstrated in prior studies to delay skin glycation damage, yet the specific active constituents underlying this pharmacological effect remain unclear. Bioactive compounds identified from WS ( W. somnifera root extract) by LC-MS were subjec...